AbCellera Biologics (ABCL) Treasury Shares (2021 - 2026)
AbCellera Biologics (ABCL) posted Treasury Shares of $10.1 million for Q1 2026, up 12.61% on a QoQ basis from $9.0 million in Q3 2025, and up 4.2% year-over-year from $9.7 million in Q1 2025.
AbCellera Biologics (ABCL) Treasury Shares (2021 - 2026) Analysis & Trends
AbCellera Biologics' Treasury Shares history runs 6 years deep, the most recent figure standing at $10.1 million for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 265,401.92 |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 34.70 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 5.14 Mn |
| 10 | AbCellera Biologics | 1.62 Bn | 1.62 Bn | - | 10.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.14 Mn |
| Mar 31, 2026 | 10.14 Mn |
| Sep 30, 2025 | 9.00 Mn |
| Sep 30, 2025 | 9.00 Mn |
| Jun 30, 2025 | 9.39 Mn |
| Jun 30, 2025 | 9.39 Mn |
| Mar 31, 2025 | 9.73 Mn |
| Mar 31, 2025 | 9.73 Mn |
| Sep 30, 2024 | 6.85 Mn |
| Sep 30, 2024 | 6.85 Mn |
| Jun 30, 2024 | 7.03 Mn |
| Jun 30, 2024 | 7.03 Mn |
| Mar 31, 2024 | 7.10 Mn |
| Mar 31, 2024 | 7.10 Mn |
| Sep 30, 2023 | 4.42 Mn |
| Sep 30, 2023 | 4.42 Mn |
| Jun 30, 2023 | 4.59 Mn |
| Jun 30, 2023 | 4.59 Mn |
| Mar 31, 2023 | 4.43 Mn |
| Mar 31, 2023 | 4.43 Mn |